Terms: = Pancreatic cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105
23 results:
1. hsa_circ_0007919 induces LIG1 transcription by binding to foxa1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
Xu L; Ma X; Zhang X; Zhang C; Zhang Y; Gong S; Wu N; Zhang P; Feng X; Guo J; Zhao M; Ren Z; Zhang P
Mol Cancer; 2023 Dec; 22(1):195. PubMed ID: 38044421
[TBL] [Abstract] [Full Text] [Related]
2. Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.
Ferguson LP; Gatchalian J; McDermott ML; Nakamura M; Chambers K; Rajbhandari N; Lytle NK; Rosenthal SB; Hamilton M; Albini S; Wartenberg M; Zlobec I; Galván JA; Karamitopoulou E; Vavinskaya V; Wascher A; Lowy AM; Schürch CM; Puri PL; Bruneau BG; Hargreaves DC; Reya T
Nat Commun; 2023 Jan; 14(1):292. PubMed ID: 36653361
[TBL] [Abstract] [Full Text] [Related]
3. CRISPR screening uncovers a central requirement for HHEX in pancreatic lineage commitment and plasticity restriction.
Yang D; Cho H; Tayyebi Z; Shukla A; Luo R; Dixon G; Ursu V; Stransky S; Tremmel DM; Sackett SD; Koche R; Kaplan SJ; Li QV; Park J; Zhu Z; Rosen BP; Pulecio J; Shi ZD; Bram Y; Schwartz RE; Odorico JS; Sidoli S; Wright CV; Leslie CS; Huangfu D
Nat Cell Biol; 2022 Jul; 24(7):1064-1076. PubMed ID: 35787684
[TBL] [Abstract] [Full Text] [Related]
4. A novel FBW7/NFAT1 axis regulates cancer immunity in sunitinib-resistant renal cancer by inducing PD-L1 expression.
Liu W; Ren D; Xiong W; Jin X; Zhu L
J Exp Clin Cancer Res; 2022 Jan; 41(1):38. PubMed ID: 35081978
[TBL] [Abstract] [Full Text] [Related]
5. Oncogenic
Kim MP; Li X; Deng J; Zhang Y; Dai B; Allton KL; Hughes TG; Siangco C; Augustine JJ; Kang Y; McDaniel JM; Xiong S; Koay EJ; McAllister F; Bristow CA; Heffernan TP; Maitra A; Liu B; Barton MC; Wasylishen AR; Fleming JB; Lozano G
Cancer Discov; 2021 Aug; 11(8):2094-2111. PubMed ID: 33839689
[TBL] [Abstract] [Full Text] [Related]
6. Effect of centralization and regionalization of pancreatic surgery on resection rates and survival.
Latenstein AEJ; Mackay TM; van der Geest LGM; van Eijck CHJ; de Meijer VE; Stommel MWJ; Vissers PAJ; Besselink MG; de Hingh IHJT;
Br J Surg; 2021 Jul; 108(7):826-833. PubMed ID: 33738473
[TBL] [Abstract] [Full Text] [Related]
7. Landmarks to identify segmental borders of the liver: A review prepared for PAM-HBP expert consensus meeting 2021.
Wakabayashi T; Benedetti Cacciaguerra A; Ciria R; Ariizumi S; Durán M; Golse N; Ogiso S; Abe Y; Aoki T; Hatano E; Itano O; Sakamoto Y; Yoshizumi T; Yamamoto M; Wakabayashi G;
J Hepatobiliary Pancreat Sci; 2022 Jan; 29(1):82-98. PubMed ID: 33484112
[TBL] [Abstract] [Full Text] [Related]
8. A small protein encoded by a putative lncRNA regulates apoptosis and tumorigenicity in human colorectal cancer cells.
Li XL; Pongor L; Tang W; Das S; Muys BR; Jones MF; Lazar SB; Dangelmaier EA; Hartford CC; Grammatikakis I; Hao Q; Sun Q; Schetter A; Martindale JL; Tang B; Jenkins LM; Robles AI; Walker RL; Ambs S; Chari R; Shabalina SA; Gorospe M; Hussain SP; Harris CC; Meltzer PS; Prasanth KV; Aladjem MI; Andresson T; Lal A
Elife; 2020 Oct; 9():. PubMed ID: 33112233
[TBL] [Abstract] [Full Text] [Related]
9. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms.
Huang B; Trujillo MA; Fujikura K; Qiu M; Chen F; Felsenstein M; Zhou C; Skaro M; Gauthier C; Macgregor-Das A; Hutchings D; Hong SM; Hruban RH; Eshleman JR; Thompson ED; Klein AP; Goggins M; Wood LD; Roberts NJ
J Pathol; 2020 Nov; 252(3):252-262. PubMed ID: 32696980
[TBL] [Abstract] [Full Text] [Related]
10. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
Ma F; Wang H; Liu K; Wang Z; Chen S
Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
[TBL] [Abstract] [Full Text] [Related]
11. BACH1 Promotes pancreatic cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition.
Sato M; Matsumoto M; Saiki Y; Alam M; Nishizawa H; Rokugo M; Brydun A; Yamada S; Kaneko MK; Funayama R; Ito M; Kato Y; Nakayama K; Unno M; Igarashi K
Cancer Res; 2020 Mar; 80(6):1279-1292. PubMed ID: 31919242
[TBL] [Abstract] [Full Text] [Related]
12. FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner.
Milan M; Balestrieri C; Alfarano G; Polletti S; Prosperini E; Spaggiari P; Zerbi A; Diaferia GR; Natoli G
EMBO J; 2019 Oct; 38(20):e102161. PubMed ID: 31531882
[TBL] [Abstract] [Full Text] [Related]
13. FOXA2 Is Required for Enhancer Priming during pancreatic Differentiation.
Lee K; Cho H; Rickert RW; Li QV; Pulecio J; Leslie CS; Huangfu D
Cell Rep; 2019 Jul; 28(2):382-393.e7. PubMed ID: 31291575
[TBL] [Abstract] [Full Text] [Related]
14. Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras
Vilimas T; Wang AQ; Patnaik S; Hughes EA; Singleton MD; Knotts Z; Li D; Frankowski K; Schlomer JJ; Guerin TM; Springer S; Drennan C; Dextras C; Wang C; Gilbert D; Southall N; Ferrer M; Huang S; Kozlov S; Marugan J; Xu X; Rudloff U
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1067-1080. PubMed ID: 30306263
[TBL] [Abstract] [Full Text] [Related]
15. Reprogramming Enhancers to Drive Metastasis.
Mostoslavsky R; Bardeesy N
Cell; 2017 Aug; 170(5):823-825. PubMed ID: 28841414
[TBL] [Abstract] [Full Text] [Related]
16. Enhancer Reprogramming Promotes pancreatic cancer Metastasis.
Roe JS; Hwang CI; Somerville TDD; Milazzo JP; Lee EJ; Da Silva B; Maiorino L; Tiriac H; Young CM; Miyabayashi K; Filippini D; Creighton B; Burkhart RA; Buscaglia JM; Kim EJ; Grem JL; Lazenby AJ; Grunkemeyer JA; Hollingsworth MA; Grandgenett PM; Egeblad M; Park Y; Tuveson DA; Vakoc CR
Cell; 2017 Aug; 170(5):875-888.e20. PubMed ID: 28757253
[TBL] [Abstract] [Full Text] [Related]
17. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
Chen S; Chen X; Sun KX; Xiu YL; Liu BL; Feng MX; Sang XB; Zhao Y
PLoS One; 2016; 11(11):e0165776. PubMed ID: 27829043
[TBL] [Abstract] [Full Text] [Related]
18. GATA-3 and foxa1 expression is useful to differentiate breast carcinoma from other carcinomas.
Davis DG; Siddiqui MT; Oprea-Ilies G; Stevens K; Osunkoya AO; Cohen C; Li XB
Hum Pathol; 2016 Jan; 47(1):26-31. PubMed ID: 26527523
[TBL] [Abstract] [Full Text] [Related]
19. Epigenetic priming of enhancers predicts developmental competence of hESC-derived endodermal lineage intermediates.
Wang A; Yue F; Li Y; Xie R; Harper T; Patel NA; Muth K; Palmer J; Qiu Y; Wang J; Lam DK; Raum JC; Stoffers DA; Ren B; Sander M
Cell Stem Cell; 2015 Apr; 16(4):386-99. PubMed ID: 25842977
[TBL] [Abstract] [Full Text] [Related]
20. Activation of protein kinase Cδ leads to increased pancreatic acinar cell dedifferentiation in the absence of MIST1.
Johnson CL; Peat JM; Volante SN; Wang R; McLean CA; Pin CL
J Pathol; 2012 Nov; 228(3):351-65. PubMed ID: 22374815
[TBL] [Abstract] [Full Text] [Related]
[Next]
